Business
Event Cardio Group's NowCardio Heart Monitor System Cleared for Sale
Event Cardio Group's NowCardio Heart Monitor System Cleared for Sale.
About this update from Ecgi Holdings Inc.
[{"type":"text","content":"\nEvent Cardio Group's NowCardio Heart Monitor System Cleared for Sale\nin Canada\nCompany Plans to Launch Leadless and Wireless Heart Monitoring Device This MonthNew York, NY--(Marketwired - July 06,2016) The NowCardioTM heart monitoring system, Event Cardio Group, Inc.'s (OTCQB:ECGI) core product, has been cleared for sale by Health Canada as a Class 2 Medical Device Locence and distribution will commence this month.\nNowCardio is a noninvasive continuous heart monitoring device that is both leadless and wireless, offering the functionality of Holter\nmonitoring, event monitoring, mobile cardiac telemetry and real-time streaming of all ECG data within a single device. The patient-friendly\nNowCardio heart monitor involves a single-lead ECG patch that allows patients to be remotely monitored for extended periods of time to\nobtain important data which is continuously transferred to a data center for immediate analysis.\nNowCardio incorporates several features designed to improve patient adherence, including: no wired leads; wireless transmitter; automatic\narrhythmia detection; patient-triggered alarm; small footprint and 24/7 patient support. It also incorporates several features designed to\nenhance diagnostic yield, including: advanced automated ECG analysis software; superior noise reduction; extended monitoring up to 32\ndays; real-time streaming of all ECG data; mobile device support; and custom electrodes without skin prep.\nVincenzo Basile M.D., B.Ed, CSCN, FRCPC, a neurologist and medical director of hospital stroke programs, said, \"The NowCardio device is a\nlightweight, comfortable and waterproof solution to real-time, beat-to-beat cardiac monitoring and undoubtedly will offer several advantages\nover the current standards. The real-time streaming of beat-to-beat data offers more rapid detection of paroxysmal atrial fibrillation and early\nidentification is vital to stroke prevention. Its small size and leadless design allows patients to be monitored without others noticing they have it\non and its waterproof design allows patients to be monitored without interfering with showering or swimming. Overall it is one of the best\ndesigns I have seen from a cardiac monitor perspective.\"\nJohn Bentivoglio, CEO of Event Cardio Group, said, \"After nearly five years of hard work and dedication, we have achieved a key milest...